Is it possible for drug shops to abide by the formal rules? The structural determinants of community medicine sales in Uganda.

health policies and all other topics health systems treatment

Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
02 2023
Historique:
received: 29 10 2022
accepted: 05 02 2023
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 3 3 2023
Statut: ppublish

Résumé

The medicines retail sector is an essential element of many health systems in Africa and Asia, but it is also well known for poor practice. In the literature, it is recognised that improvements in the sector can only be made if more effective forms of governance and regulation can be identified. Recent debate suggests that interventions responsive to structural constraints that shape and underpin poor practice is a useful way forward. This paper presents data from a mixed-methods study conducted to explore regulation and the professional, economic and social constraints that shape rule breaking among drug shops in one district in Uganda. Our findings show that regulatory systems are undermined by frequent informal payments, and that although drug shops are often run by qualified staff, many are unlicensed and sell medicines beyond their legal permits. Most shops have either a small profit or a loss and rely on family and friends for additional resources as they compete in a highly saturated market. We argue that in the current context, drug shop vendors are survivalist entrepreneurs operating in a market in which it is extremely difficult to abide by policy, remain profitable and provide a service to the community. Structural changes in the medicines market, including removing unqualified sellers and making adjustments to policy are likely prerequisite if drug shops are to become places where individuals can earn a living, abide by the rules and facilitate access to medicines for people living in some of the world's poorest countries.

Identifiants

pubmed: 36822666
pii: bmjgh-2022-011097
doi: 10.1136/bmjgh-2022-011097
pmc: PMC9950907
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/N003810/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R00370X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S013016/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V035592/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Health Policy Plan. 2007 Nov;22(6):393-403
pubmed: 17921151
Res Social Adm Pharm. 2020 Sep;16(9):1328-1329
pubmed: 32417072
Antimicrob Resist Infect Control. 2023 Feb 11;12(1):10
pubmed: 36774512
J Pharm Policy Pract. 2020 Sep 10;13:55
pubmed: 32944257
BMC Health Serv Res. 2020 Jul 15;20(1):656
pubmed: 32669092
J Pharm Policy Pract. 2021 Nov 16;14(Suppl 1):94
pubmed: 34784982
Health Econ. 2009 Jun;18(6):727-42
pubmed: 19301420
BMJ Glob Health. 2017 Jan 11;2(1):e000067
pubmed: 28588992
Health Policy Plan. 2019 Sep 1;34(7):529-543
pubmed: 31377775
BMC Health Serv Res. 2012 Jul 27;12:223
pubmed: 22838649
BMJ Open. 2016 Mar 15;6(3):e010632
pubmed: 26980439
Cult Med Psychiatry. 1992 Jun;16(2):163-86
pubmed: 1395694
BMJ Glob Health. 2017 Sep 22;2(3):e000457
pubmed: 29018588
J Pharm Policy Pract. 2021 Aug 24;14(1):72
pubmed: 34429161
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
Soc Sci Med. 2013 Nov;97:220-7
pubmed: 24016728
PLoS One. 2015 Jan 28;10(1):e0117165
pubmed: 25629900
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):203-18
pubmed: 18165494
Lancet Infect Dis. 2018 Jan;18(1):18-20
pubmed: 29303731
BMC Health Serv Res. 2020 Jun 22;20(1):567
pubmed: 32571381
Antibiotics (Basel). 2021 Aug 23;10(8):
pubmed: 34439074
Health Policy Plan. 2014 May;29(3):323-7
pubmed: 23564372
PLoS One. 2015 Jul 22;10(7):e0129545
pubmed: 26200467
Soc Sci Med. 2022 May;300:113941
pubmed: 33926753
Int J Health Policy Manag. 2019 Nov 01;8(11):672-674
pubmed: 31779294
Malar J. 2017 Oct 23;16(1):425
pubmed: 29061148
Health Res Policy Syst. 2021 Aug 11;19(Suppl 2):52
pubmed: 34380523
Antimicrob Resist Infect Control. 2015 Aug 20;4:33
pubmed: 26301089
Lancet. 2016 Aug 6;388(10044):613-21
pubmed: 27358250
BMJ Glob Health. 2017 Sep 13;2(Suppl 3):e000334
pubmed: 29259824
Cochrane Database Syst Rev. 2016 Aug 16;(8):CD008856
pubmed: 27528494
Antimicrob Resist Infect Control. 2021 Jan 14;10(1):13
pubmed: 33446266
BMJ Glob Health. 2021 Jul;6(7):
pubmed: 34326070
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33272939
BMC Public Health. 2021 Jun 3;21(1):1056
pubmed: 34082726
Glob Public Health. 2020 Nov;15(11):1674-1688
pubmed: 32493119
Antimicrob Resist Infect Control. 2015 Jul 21;4:30
pubmed: 26199723
Int J Health Policy Manag. 2020 Jul 01;9(7):286-296
pubmed: 32613800

Auteurs

Eleanor Hutchinson (E)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK eleanor.hutchinson@lshtm.ac.uk.

Kristian Schultz Hansen (KS)

National Research Centre for the Working Environment, Kobenhavn, Denmark.

Jacquellyn Sanyu (J)

Department of Health Policy, Planning and Management, Makerere University School of Public Health, Kampala, Uganda.

Lydia Peace Amonya (LP)

Infectious Diseases Research Collaboration, Kampala, Central Region, Uganda.

Sunday Mundua (S)

Makerere University College of Health Sciences, Kampala, Uganda.

Dina Balabanova (D)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.

Sian E Clarke (SE)

Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine Faculty of Infectious and Tropical Diseases, London, UK.

Freddy Eric Kitutu (FE)

Makerere University College of Health Sciences, Kampala, Uganda.
Department of Pharmacy, Makerere University School of Health Sciences, Kampala, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH